Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial
A Senft, R de Bree, OS Hoekstra, DJ Kuik… - Radiotherapy and …, 2008 - Elsevier
BACKGROUND AND PURPOSE: The aim of the study was to define the added value of
whole body FDG-PET in screening for distant metastases in patients with head and neck …
whole body FDG-PET in screening for distant metastases in patients with head and neck …
Screening for distant metastases in patients with head and neck cancer: Is there a role for 18FDG-PET?
J Brouwer, A Senft, R De Bree, EFI Comans… - Oral oncology, 2006 - Elsevier
The detection of distant metastases and second primary tumours at the time of initial evaluation
changes the prognosis and influences the selection of treatment modality in patients with …
changes the prognosis and influences the selection of treatment modality in patients with …
Pretreatment screening on distant metastases and head and neck cancer patients: validation of risk factors and influence on survival
TT Peters, A Senft, OS Hoekstra, JA Castelijns, BI Witte… - Oral Oncology, 2015 - Elsevier
Background and purpose Previously identified high risk factors for development of distant
metastases are: three or more lymph node metastases, bilateral lymph node metastases, …
metastases are: three or more lymph node metastases, bilateral lymph node metastases, …
Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients
CA Uyl-de Groot, A Senft, R de Bree… - Journal of Nuclear …, 2010 - Soc Nuclear Med
The aim of the study was to define the cost-effectiveness of whole-body 18 F-FDG PET, as
compared with chest CT, in screening for distant metastases in patients with head and neck …
compared with chest CT, in screening for distant metastases in patients with head and neck …
Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma
BJM Braakhuis, A Senft, R de Bree, J de Vries… - Journal of clinical …, 2006 - jcp.bmj.com
Background: For breast and prostate cancer, a gene expression signature of the tumour is
associated with the development of distant metastases. Regarding head and neck squamous …
associated with the development of distant metastases. Regarding head and neck squamous …
Detection of distant metastases in head and neck cancer: changing landscape
R de Bree, A Senft, A Coca-Pelaz, L Kowalski… - Advances in …, 2018 - Springer
As head and neck squamous cell carcinoma (HNSCC) patients with distant metastases (DM)
were generally treated only palliatively, the value of screening for DM was usually limited to …
were generally treated only palliatively, the value of screening for DM was usually limited to …
[HTML][HTML] Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm
A Senft, OS Hoekstra, BI Witte, CR Leemans… - European Archives of …, 2016 - Springer
In patients with head and neck squamous cell carcinoma and high-risk factors, the combination
of whole body FDG-PET and contrast-enhanced chest CT has the highest sensitivity and …
of whole body FDG-PET and contrast-enhanced chest CT has the highest sensitivity and …
[HTML][HTML] Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients
A Senft, R De Bree, RP Golding, EFI Comans… - Molecular Imaging and …, 2011 - Springer
Purpose The aim of the study was to assess the interobserver variability in chest computed
tomography (CT) and whole body 2-deoxy-2-[ 18 F]fluoro-d-glucose positron emission …
tomography (CT) and whole body 2-deoxy-2-[ 18 F]fluoro-d-glucose positron emission …
[HTML][HTML] The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients
A Senft, G Yildirim, OS Hoekstra, JA Castelijns… - European Archives of …, 2017 - Springer
The presence of distant metastases at initial evaluation influences treatment selection, since
no effective systemic treatment for disseminated head and neck squamous cell carcinoma (…
no effective systemic treatment for disseminated head and neck squamous cell carcinoma (…
[HTML][HTML] Pretreatment screening for distant metastases in the Dutch head and neck centers: 10 years later
A Senft, OS Hoekstra, JA Castelijns… - European Archives of …, 2016 - Springer
To evaluate the current practice and change in practice concerning screening for distant
metastases in head and neck squamous cell carcinoma patients, we performed a survey with …
metastases in head and neck squamous cell carcinoma patients, we performed a survey with …